Inventor · disambiguated record
Douglas Robert Cary
Also filed as: CARY DOUGLAS R · CARY DOUGLAS ROBERT
11 granted patents·3 pending applications·499 citations·filing 2000–2025
90Inventor score
Files withTAKEDA PHARMACEUTICALS CO6PEPTIDREAM INC3UNIV CALIFORNIA2NISSAN CHEMICAL CORP1SUNESIS PHARMACEUTICALS INC1
Top patents by PatentIndex Score
14 records- 0198US6682938B1Glucose sensing molecules having selected fluorescent propertiesUNIV CALIFORNIA·Filed 2000·Granted Jan 27, 2004·244 cites·24 claims
- 0298US6673625B2Saccharide sensing molecules having enhanced fluorescent propertiesUNIV CALIFORNIA·Filed 2001·Granted Jan 6, 2004·195 cites·8 claims
- 0392US7132568B2Aspartyl protease inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2003·Granted Nov 7, 2006·34 cites·48 claims
- 0484US10696651B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jun 30, 2020·3 cites·9 claims
- 0584US9278931B2Cyclopropaneamine compoundTOMITA NAOKI·Filed 2012·Granted Mar 8, 2016·17 cites·21 claims
- 0682US12240871B2Method for producing peptide compoundNISSAN CHEMICAL CORP·Filed 2020·Granted Mar 4, 2025·2 cites·20 claims
- 0777US9957251B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted May 1, 2018·3 cites·10 claims
- 0874US12435063B2Nitrogen containing heterocycles as CDK12 inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Oct 7, 2025·0 cites·15 claims
- 0966US9745325B2Fused heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Aug 29, 2017·1 cites·17 claims
- 1063US11584737B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Feb 21, 2023·0 cites·15 claims
- 1158US2024400499A1Novel amino acid derivativesPEPTIDREAM INC·Filed 2024·Application pending·0 cites
- 1256US2023257343A1Novel amino acid derivativesPEPTIDREAM INC·Filed 2023·Application pending·0 cites
- 1344US2025296915A1Novel amino acid derivativesPEPTIDREAM INC·Filed 2025·Application pending·0 cites
- 1441US9682925B2Cyclopropaneamine compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 20, 2017·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →